SEC Comment Letter for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686) (TEVA) — Mar 31, 2011

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)
Date: March 31, 2011 · CIK: 0000818686 · Accession: 0000000000-11-019694

View on Edgar

AI Filing Summary & Sentiment

Date

March 31, 2011

Author

Melissa N. Rocha

Form

UPLOAD

Company

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)

Letter

March 31, 2011 Mr. Eyal Desheh Chief Financial Officer Teva Pharmaceutical Industries Limited 5 Basel Street P.O. Box 3190 Petach, Tikva 49131, Israel

Re: Teva Pharmaceutical Industries Limited Form 20-F for the Fiscal Year Ended December 31, 2010 File No . 0-16174

Dear Mr. Desheh: We have completed our review of your fili ngs and do not have any further comments at this time. Sincerely,

Melissa N. Rocha Accounting Branch Chief

Show Raw Text

March 31, 2011

Mr. Eyal Desheh
Chief Financial Officer Teva Pharmaceutical Industries Limited 5 Basel Street P.O. Box 3190 Petach, Tikva  49131, Israel

Re: Teva Pharmaceutical Industries Limited
  Form 20-F for the Fiscal Year Ended December 31, 2010
  File No . 0-16174

Dear Mr. Desheh:
 We have completed our review of your fili ngs and do not have any further comments at
this time.
Sincerely,

Melissa N. Rocha
Accounting Branch Chief

SecProbe.io